Schedule 13G ownership disclosure
Arcus Biosciences Inc
Common Stock · CUSIP: 03969F109
Event date: 2025-12-31
- Filing-level shares
- 12,736,927
- Percent of class
- 10.4%
- BlackRock, Inc.
Shares: 12,736,927 · Class: 10.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000038
- Form type
- SCHEDULE 13G/A
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Jan 08, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership